BigHat Biosciences and Lilly Partner on AI-Driven Antibody Therapeutics BigHat Biosciences, a pioneering biotechnology company leveraging machine learning (ML) to guide antibody discovery and development, has announced a strategic collaboration…
Thermo Fisher Opens San Diego Center to Boost Cell Therapy Development Thermo Fisher Scientific Inc., the global leader in serving science, has officially opened its Advanced Therapies Collaboration Center (ATxCC)…
Artedrone’s SASHA Robot Shows Autonomous Stroke Clot Removal in Preclinical Studies Artedrone, a medical technology company backed by Truffle Capital, has announced promising preclinical results for its innovative SASHA micro-robot—an…
ACIP Expands Pfizer’s RSV Vaccine Recommendation to At-Risk Adults 50–59 Pfizer Inc. (NYSE: PFE) announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
GC Therapeutics Adds Industry Veterans Kai-Hsin Chang and Azadeh Golipour to Leadership Team GC Therapeutics (GCTx), a trailblazing biotechnology company advancing innovative induced pluripotent stem cell (iPSC)-based therapies, today announced…
ABEC Unveils Breakthrough Single-Use Bioreactor for Cell Therapy ABEC, a global leader in engineering and manufacturing solutions for the biotechnology industry, has announced the launch of its Advanced Therapy Bioreactor…
Aptar: iPUMP® Boosts Adherence to SLIT Allergy Treatment Aptar Digital Health, a leader in digital health solutions, is pleased to announce the positive results from the SPEED1 survey, which demonstrate…
Nuclera Boosts eProtein Discovery for Membrane Protein Production Nuclera, a biotechnology company revolutionizing protein expression and optimization, has announced a major enhancement to its eProtein Discovery™ system: a new workflow…
AdvanCell Secures $18M MRFF Grant for Prostate Cancer Therapy AdvanCell, a clinical-stage radiopharmaceutical company pioneering next-generation cancer therapeutics, has been awarded $18 million in funding from the Australian Federal Government…
Future Pak, LLC (“Future Pak”), a Michigan-based pharmaceutical packaging and manufacturing company, has officially announced the submission of two formal acquisition proposals to Theratechnologies Inc. (“Theratechnologies”), a biopharmaceutical company listed…
QIAGEN Surpasses Q1 2025 Outlook, Raises Full-Year EPS Forecast QIAGEN NV (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced strong preliminary results for the first quarter of 2025, surpassing both…
Sentynl Therapeutics Unveils First Clinical Evidence Supporting NULIBRY® for Molybdenum Cofactor Deficiency Type A Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly owned by Zydus Lifesciences, Ltd., has announced the…